Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.08 USD | +0.50% | +5.50% | -15.84% |
Business Summary
Number of employees: 912
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies
100.0
%
| 245 | 100.0 % | 305 | 100.0 % | +24.39% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
73.5
%
| 186 | 75.8 % | 224 | 73.5 % | +20.54% |
Japan
21.5
%
| 57 | 23.0 % | 66 | 21.5 % | +16.33% |
Europe and Rest of World
5.0
%
| 3 | 1.2 % | 15 | 5.0 % | +434.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 55 | 12-09-09 |
Sara Bonstein
DFI | Director of Finance/CFO | 43 | 20-01-30 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-12-18 |
Roger Adsett
COO | Chief Operating Officer | 55 | 16-09-26 |
Chief Tech/Sci/R&D Officer | - | 10-11-30 | |
Eleanor Barisser
IRC | Investor Relations Contact | - | - |
Michael Smith
LAW | General Counsel | 47 | 14-03-31 |
Corporate Officer/Principal | 59 | 15-02-28 | |
Drayton Wise
PRN | Corporate Officer/Principal | 49 | 14-01-31 |
S. Schaeffer
HRO | Human Resources Officer | 55 | 12-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 20-03-31 |
Al Altomari
BRD | Director/Board Member | 65 | 12-08-01 |
Melvin Sharoky
BRD | Director/Board Member | 73 | 01-04-30 |
David McGirr
BRD | Director/Board Member | 69 | 13-10-29 |
David Brennan
BRD | Director/Board Member | 70 | 14-05-28 |
Will Lewis
CEO | Chief Executive Officer | 55 | 12-09-09 |
Director/Board Member | 57 | 19-10-31 | |
Director/Board Member | 66 | 18-11-07 | |
Yao Lee
BRD | Director/Board Member | 54 | 18-05-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 148,555,217 | 146,937,967 ( 98.91 %) | 0 | 98.91 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.84% | 3.86B | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- INSM Stock
- Company Insmed Incorporated